Maze Therapeutics CSBO Sells: Reading Insider Moves
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
Explore when bonds may be preferred over the Sp500 in retirement and how a cautious mix can protect assets while supporting withdrawals. This intro covers key timing considerations and conservative principles.
23,766 articlesWhen a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
A midstream-focused energy ETF aims to deliver reliable income through toll-road style fees rather than volatile comm...
A major fund reportedly dumped million in Netskope stock after the cloud-security name sank about half from its IPO l...
Tapestry reports a record quarter as Coach powerfully taps Gen Z demand with a Goldilocks mix of luxury and accessibi...
Intel posted a stronger-than-expected Q1, yet rising costs and cash-flow strain raise the risk of a sharper pullback....
A ransomware attack on Canvas disrupted finals across thousands of schools as the ShinyHunters group claimed responsi...
Bitcoin profit-taking is picking up as the bear-market rally continues. CryptoQuant reports rising on-chain profits a...
Bitcoin briefly slips below the $80,000 level before rebounding, signaling a shallow pullback rather than a crash. On...
Mozilla’s latest security push uses Mythos AI to slash a year of fixes into one month, highlighting how AI-assisted d...
Hundreds of families in Guerrero have fled their homes after a cartel armed with drones attacked rural communities, t...
Bitmine Immersion Technologies slows weekly ETH purchases while maintaining a bullish stance. Tom Lee signals a forth...
FuelCell Energy jumps 18% in midday trading, powering a broad rally for fuel-cell names as AI infrastructure and grid...